Viewing Study NCT05101356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-05-15 @ 5:44 PM
Study NCT ID: NCT05101356
Status: RECRUITING
Last Update Posted: 2024-05-21
First Post: 2021-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
Sponsor: Tianhong Li
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Adenocarcinoma View
None Advanced Malignant Solid Neoplasm View
None Metastatic Adenocarcinoma View
None Metastatic Malignant Solid Neoplasm View
None Recurrent Adenocarcinoma View
None Recurrent Malignant Solid Neoplasm View
Keywords: